DANIEL PERRY: Open Payments
NPI 1710352083 · ARROYO GRANDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 48 payments from 10 companies in 2025. Trend: 2023 $1,623 · 2024 $1,048 · 2025 $884
Food & beverage: $801Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $320 |
| ABBVIE INC. | 12 | $165 |
| Incyte Corporation | 5 | $118 |
| Amgen Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| LEO Pharma Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, OPZELURA, OTEZLA, DUPIXENT, TALTZ, Odomzo, ANZUPGO.
Industry payments across CA — which companies pay providers there.
